Samchundang Pharmaceutical Obtains Patent for Ophthalmic Pharmaceutical Composition
[Asia Economy Reporter Eunmo Koo] Samchundang Pharmaceutical announced on the 7th that it has acquired a patent related to an ophthalmic pharmaceutical composition. The company explained the patent as “a technology for an ophthalmic formulation containing aflibercept, a macular degeneration treatment, as an active ingredient, which enables long-term stability of material properties and biological activity under long-term storage and accelerated conditions.”
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- The Unexpected Story of an American Man Who Won the Lottery 18 Times in 29 Years: "My Real Luck Is My Wife"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
